Form 4: Ginkgo Bioworks CFO Mark Dmytruk Reports Stock Transactions

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On May 20 and 21, 2025, Mark Dmytruk, the CFO of Ginkgo Bioworks Holdings, engaged in transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
• Dmytruk acquired 454, 453, and 572 shares of Class A Common Stock through the vesting of RSUs on May 20, 2025.
• He then sold 706 shares of Class A Common Stock on May 21, 2025, at a price of $7.585 per share.
• These sales were to cover tax withholding obligations related to the vesting of the RSUs and do not represent discretionary trades.
• The RSUs vest in 48 equal monthly installments, beginning on April 1, 2023, and April 1, 2024, respectively.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but the impact is likely minimal given the purpose of covering tax obligations.

Key Dates

Keywords

Ginkgo Bioworks, Dmytruk, CFO, DNA, Form 4, SEC, Stock, RSU, Restricted Stock Units, Vesting, Tax Withholding, Class A Common Stock